Cargando…
In Vivo MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells
Cancer vaccination using tumor antigen-primed dendritic cells (DCs) was introduced in the clinic some 25 years ago, but the overall outcome has not lived up to initial expectations. In addition to the complexity of the immune response, there are many factors that determine the efficacy of DC therapy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477715/ https://www.ncbi.nlm.nih.gov/pubmed/34581954 http://dx.doi.org/10.1007/s11307-021-01647-4 |